We received your registration! A confirmation email has been sent to [email address]. We look forward to seeing you at this
For more information and resources,
NUPLAZID® is an FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis.
Register Here
Acadia Educational Programs
Thank you for your interest in an upcoming Acadia Educational Live Program or Webinar. These programs will feature an Acadia sales representative who will share important educational material. Events, both in-person and virtual will feature a Journey Ambassador, who will share their personal journey treating and dealing with the symptoms of Parkinson’s-related hallucinations and delusions. Please fill out the form below to register for an upcoming program. If there are no programs in your region, please consider signing up for a webinar instead.
Event Details:
Fill out the form below to register for upcoming Acadia Educational Programs
Required fields marked with an *
In order to register you for the program, we will need to collect personal information, such as your name and contact information, and any health information that you provide. We will use your information only in connection with your program registration. We do not and will not sell your personal information and we will not share with any third parties for any cross-context behavioral advertising. We will retain your personal information only as long as legally required. To learn more about our privacy practices and how to exercise your privacy rights, please review our Privacy Notice and our Health Information Privacy Policy by visiting https://acadia.com/privacy/.
What is the most important information I should know about NUPLAZID?
- Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia).
- NUPLAZID is not approved for the treatment of patients with dementia who experience psychosis unless their hallucinations and delusions are related to Parkinson’s disease.
Who should not take NUPLAZID?
- Do not take NUPLAZID if you have had an allergic reaction to any of the ingredients in NUPLAZID. Allergic reactions have included rash, hives, swelling of the tongue, mouth, lips, or face, throat tightness, and shortness of breath.
- Do not take NUPLAZID if you have certain heart conditions that change your heart rhythm. It is important to talk to your healthcare provider about this possible side effect. Call your healthcare provider if you feel a change in your heartbeat.
What other warnings should I know about NUPLAZID?
- QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to prolong the QT interval. Tell your healthcare provider about all the medicines you take or have recently taken.
Please also see What is the most important information I should know about NUPLAZID?
What medicine might interact with NUPLAZID?
- Tell your healthcare provider about all the medicines you take. Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.
What are the common side effects of NUPLAZID?
- The common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You can also call ACADIA Pharmaceuticals Inc. at 1-844-4ACADIA (1-844-422-2342).
Indication
NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.
How should I take NUPLAZID?
The recommended dose of NUPLAZID is one 34 mg capsule once per day, taken by mouth, with or without food.
NUPLAZID is available as 34 mg capsules and 10 mg tablets.
Please read the full Prescribing Information, including Boxed WARNING.